Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-065241

Chief Financial Officer acquired 19,841 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-23 Exercise or conversion : show line 1 in the form +19,841 $5.04 $99,999 20,774 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-23 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −19,841 $5.04 2028-11-02 10,000 480,159 D
Loading xslF345X03/doc4.xml…